These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 2775212)

  • 21. Consortium for osteogenesis imperfecta mutations in the helical domain of type I collagen: regions rich in lethal mutations align with collagen binding sites for integrins and proteoglycans.
    Marini JC; Forlino A; Cabral WA; Barnes AM; San Antonio JD; Milgrom S; Hyland JC; Körkkö J; Prockop DJ; De Paepe A; Coucke P; Symoens S; Glorieux FH; Roughley PJ; Lund AM; Kuurila-Svahn K; Hartikka H; Cohn DH; Krakow D; Mottes M; Schwarze U; Chen D; Yang K; Kuslich C; Troendle J; Dalgleish R; Byers PH
    Hum Mutat; 2007 Mar; 28(3):209-21. PubMed ID: 17078022
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recurrence of lethal osteogenesis imperfecta due to parental mosaicism for a mutation in the COL1A2 gene of type I collagen. The mosaic parent exhibits phenotypic features of a mild form of the disease.
    Edwards MJ; Wenstrup RJ; Byers PH; Cohn DH
    Hum Mutat; 1992; 1(1):47-54. PubMed ID: 1301191
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Destabilization of osteogenesis imperfecta collagen-like model peptides correlates with the identity of the residue replacing glycine.
    Beck K; Chan VC; Shenoy N; Kirkpatrick A; Ramshaw JA; Brodsky B
    Proc Natl Acad Sci U S A; 2000 Apr; 97(8):4273-8. PubMed ID: 10725403
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The substitution of arginine for glycine 85 of the alpha 1(I) procollagen chain results in mild osteogenesis imperfecta. The mutation provides direct evidence for three discrete domains of cooperative melting of intact type I collagen.
    Deak SB; Scholz PM; Amenta PS; Constantinou CD; Levi-Minzi SA; Gonzalez-Lavin L; Mackenzie JW
    J Biol Chem; 1991 Nov; 266(32):21827-32. PubMed ID: 1718984
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Substitution of glycine-172 by arginine in the alpha 1 chain of type I collagen in a patient with osteogenesis imperfecta, type III.
    Mackay K; De Paepe A; Nuytinck L; Dalgleish R
    Hum Mutat; 1994; 3(3):324-6. PubMed ID: 8019571
    [No Abstract]   [Full Text] [Related]  

  • 26. Delayed triple helix formation of mutant collagen from patients with osteogenesis imperfecta.
    Raghunath M; Bruckner P; Steinmann B
    J Mol Biol; 1994 Feb; 236(3):940-9. PubMed ID: 8114103
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Osteogenesis imperfecta. The position of substitution for glycine by cysteine in the triple helical domain of the pro alpha 1(I) chains of type I collagen determines the clinical phenotype.
    Starman BJ; Eyre D; Charbonneau H; Harrylock M; Weis MA; Weiss L; Graham JM; Byers PH
    J Clin Invest; 1989 Oct; 84(4):1206-14. PubMed ID: 2794057
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Two cysteine substitutions in procollagen I: a glycine replacement near the N-terminus of alpha 1(I) chain causes lethal osteogenesis imperfecta and a glycine replacement in the alpha 2(I) chain markedly destabilizes the triple helix.
    Fertala A; Westerhausen A; Morris G; Rooney JE; Prockop DJ
    Biochem J; 1993 Jan; 289 ( Pt 1)(Pt 1):195-9. PubMed ID: 8424758
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An alpha2(I) glycine to aspartate substitution is responsible for the presence of a kink in type I collagen in a lethal case of osteogenesis imperfecta.
    Forlino A; Keene DR; Schmidt K; Marini JC
    Matrix Biol; 1998 Dec; 17(8-9):575-84. PubMed ID: 9923651
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recombinant collagen studies link the severe conformational changes induced by osteogenesis imperfecta mutations to the disruption of a set of interchain salt bridges.
    Xu K; Nowak I; Kirchner M; Xu Y
    J Biol Chem; 2008 Dec; 283(49):34337-44. PubMed ID: 18845533
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cysteine in the triple-helical domain of one allelic product of the alpha 1(I) gene of type I collagen produces a lethal form of osteogenesis imperfecta.
    Steinmann B; Rao VH; Vogel A; Bruckner P; Gitzelmann R; Byers PH
    J Biol Chem; 1984 Sep; 259(17):11129-38. PubMed ID: 6469997
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nuclear magnetic resonance shows asymmetric loss of triple helix in peptides modeling a collagen mutation in brittle bone disease.
    Liu X; Kim S; Dai QH; Brodsky B; Baum J
    Biochemistry; 1998 Nov; 37(44):15528-33. PubMed ID: 9799516
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthetic, Register-Specific, AAB Heterotrimers to Investigate Single Point Glycine Mutations in Osteogenesis Imperfecta.
    Acevedo-Jake AM; Clements KA; Hartgerink JD
    Biomacromolecules; 2016 Mar; 17(3):914-21. PubMed ID: 26859706
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Arginine for glycine substitution in the triple-helical domain of the products of one alpha 2(I) collagen allele (COL1A2) produces the osteogenesis imperfecta type IV phenotype.
    Wenstrup RJ; Cohn DH; Cohen T; Byers PH
    J Biol Chem; 1988 Jun; 263(16):7734-40. PubMed ID: 2897363
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Heterozygosity for a large deletion in the alpha 2(I) collagen gene has a dramatic effect on type I collagen secretion and produces perinatal lethal osteogenesis imperfecta.
    Willing MC; Cohn DH; Starman B; Holbrook KA; Greenberg CR; Byers PH
    J Biol Chem; 1988 Jun; 263(17):8398-404. PubMed ID: 3372533
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular mechanism of alpha 1(I)-osteogenesis imperfecta/Ehlers-Danlos syndrome: unfolding of an N-anchor domain at the N-terminal end of the type I collagen triple helix.
    Makareeva E; Cabral WA; Marini JC; Leikin S
    J Biol Chem; 2006 Mar; 281(10):6463-70. PubMed ID: 16407265
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predicting the clinical lethality of osteogenesis imperfecta from collagen glycine mutations.
    Bodian DL; Madhan B; Brodsky B; Klein TE
    Biochemistry; 2008 May; 47(19):5424-32. PubMed ID: 18412368
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Four new cases of lethal osteogenesis imperfecta due to glycine substitutions in COL1A1 and genes. Mutations in brief no. 152. Online.
    Mottes M; Gomez Lira M; Zolezzi F; Valli M; Lisi V; Freising P
    Hum Mutat; 1998; 12(1):71-2. PubMed ID: 10627137
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Three novel type I collagen mutations in osteogenesis imperfecta type IV probands are associated with discrepancies between electrophoretic migration of osteoblast and fibroblast collagen.
    Sarafova AP; Choi H; Forlino A; Gajko A; Cabral WA; Tosi L; Reing CM; Marini JC
    Hum Mutat; 1998; 11(5):395-403. PubMed ID: 9600458
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Osteogenesis imperfecta phenotypes resulting from serine for glycine substitutions in the alpha2(I) collagen chain.
    Nuytinck L; Wettinck K; Freund M; Van Maldergem L; Fabry G; De Paepe A
    Eur J Hum Genet; 1997; 5(3):161-7. PubMed ID: 9272740
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.